Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers

Clinical Biochemistry

Volumn 42, Issue 16-17, 2009, Pages 1635-1641

  Borucki, Katrin ^a   Weikert, Cornelia ^b,c   Fisher, Eva ^b   Jakubiczka, Sibylle ^a   Luley, Claus ^a   Westphal, Sabine ^a   Dierkes, Jutta ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c Institute for Social Medicine   (Germany)

Author keywords

Bilirubin; Caucasians; Haplotypes; UDP glucuronosyltransferases

Indexed keywords

BILIRUBIN; DNA; GLUCURONOSYLTRANSFERASE 1A1;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CAUCASIAN; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; VOLUNTEER;

ADULT; BASE SEQUENCE; BILIRUBIN; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GERMANY; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 70349964671     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.08.011     Document Type: Article

References (30)

1. Mackenzie P.I., Bock K.W., Burchell B., Guillemette C., Ikushiro S., Iyanagi T., et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics 15 10 (2005) 677-685
2. Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K., et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11 4 (2001) 357-368
3. Miners J.O., McKinnon R.A., and Mackenzie P.I. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology 181-182 (2002) 453-456
4. Bosma P.J., Chowdhury J.R., Bakker C., Gantla S., de Boer A., Oostra B.A., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 333 18 (1995 Nov 2) 1171-1175
5. Beutler E., Gelbart T., and Bemina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc. Natl. Acad. Sci. U. S. A. 95 14 (1998 Jul 7) 8170-8174
6. Borlak J., Thum T., Landt O., Erb K., and Hermann R. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects. Hepatology 32 4 Pt 1 (2000) 792-795
7. Kaniwa N., Kurose K., Jinno H., Tanaka-Kagawa T., Saito Y., Saeki M., et al. Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C > T (P229L) found in an African-American. Drug Metab. Dispos. 33 3 (2005) 458-465
8. Innocenti F., Grimsley C., Das S., Ramírez J., Cheng C., Kuttab-Boulos H., et al. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Pharmacogenetics 12 9 (2002 Dec) 725-733 Erratum in: Pharmacogenetics. 2003 Mar;13(3):183
9. Ki C.S., Lee K.A., Lee S.Y., Kim H.J., Cho S.S., Park J.H., et al. Haplotype structure of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population. Clin. Chem. 49 12 (2003) 2078-2081
10. Maruo Y., D'Addario C., Mori A., Iwai M., Takahashi H., Sato H., and Takeuchi Y. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum. Genet. 115 6 (2004) 525-526
11. Sugatani J., Yamakawa K., Yoshinari K., Machida T., Takagi H., Mori M., et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem. Biophys. Res. Commun. 292 2 (2002 Mar 29) 492-497
12. Strassburg C.P. Pharmacogenetics of Gilbert's syndrome. Pharmacogenomics 9 6 (2008) 703-715
13. Ferraris A., D'Amato G., Nobili V., Torres B., and Marcellini M. Dallapiccola B. Combined test for UGT1A1-3279T > G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients. Genet. Test 10 2 (2006) 121-125
14. Innocenti F., Undevia S.D., Iyer L., Chen P.X., Das S., Kocherginsky M., et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J. Clin. Oncol. 22 8 (2004 Apr 15) 1382-1388
15. Kitagawa C., Ando M., Ando Y., Sekido Y., Wakai K., Imaizumi K., et al. Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase 1A1 gene and irinotecan toxicity. Pharmacogenet. Genomics 15 1 (2005) 35-41
16. Akaba K., Kimura T., Sasaki A., Tanabe S., Ikegami T., Hashimoto M., et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem. Mol. Biol. Int. 46 1 (1998) 21-26
17. Akaba K., Kimura T., Sasaki A., Tanabe S., Wakabayashi T., Hiroi M., et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese. J. Hum. Genet. 44 1 (1999) 22-25
18. Sava M., and Kraemer D.M. Heterozygous G71R-mutation causing Gilbert's syndrome in one of 103 random persons of German descent. J. Hepatol. 42 5 (2005) 778-779
19. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Bélanger A., et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 4 (1997) 255-269
20. Wahlefeld A.W., Herz G., and Bernt E. Modification of the Malloy-Evelyn method for a simple, reliable determination of total bilirubin in serum [Abstract]. Scand. J. Clin. Lab. Invest. 29 Suppl 126 (1972) 11-12
21. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., and Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered. 53 (2002) 79-91
22. Coté J.F., Kirzin S., Kramar A., Mosnier J.F., Diebold M.D., Soubeyran I., et al. UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clin. Cancer Res. 13 (2007) 3269-3275
23. *28. Pharmacogenet. Genomics. 17 7 (2007) 497-504
24. *28 promoter polymorphism. Int. J. Clin. Pharmacol. Ther. 40 6 (2002) 233-240
25. Costa E., Vieira E., and Dos Santos R. The polymorphism c.-3279T > G in the phenobarbital-responsive enhancer module of the bilirubin UDP-glucuronosyltransferase gene is associated with Gilbert syndrome. Clin. Chem. 51 11 (2005) 2204-2206
26. Jirsa M., Petrasek J., and Vitek L. Linkage between A(TA)7TAA and -3279T > G mutations in UGT1A1 is not essential for pathogenesis of Gilbert syndrome. Liver Int. 26 10 (2006) 1302-1303
27. Innocenti F., Liu W., Chen P., Desai A.A., Das S., and Ratain M.J. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenet. Genomics 15 5 (2005 May) 295-301
28. *28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 114 14 (2006 Oct) 1476-1481
29. *28 allele is not associated with coronary heart disease: the ECTIM Study. Clin. Chem. 52 12 (2006) 2313-2314
30. *28 allele and coronary heart disease: the Rotterdam Study. Clin. Chem. 49 7 (2003) 1180-1181